Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis

Tuberculosis

Volumn 92, Issue 3, 2012, Pages 260-263

  Rey Jurado, Emma ^a   Tudó, Griselda ^a   Martínez, José Antonio ^b   González Martín, Julian ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

M. tuberculosis; Synergism; Three drug combination

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; RIFAMPIN;

EID: 84859514701     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.01.005     Document Type: Article

References (14)

1. WHO Multidrug and extensively resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010 World Health Organization
2. WHO Treatment of tuberculosis: guidelines 4th ed. 2009 World Health Organization Geneva
3. A.S. Ginsburg, J.H. Grosset, and W.R. Bishai Fluoroquinolone, tuberculosis, and resistance Lancet Infect Dis 7 2003 432 442
4. D. Kaur, and G.H. Khuller In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria Int J Antimicrob Agents 17 2001 51 55
5. A.D. Logu, V. Onnis, B. Saddi, C. Congiu, M.L. Shivo, and M.T. Cocco Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis J Antimicrob Chemother 49 2002 275 282
6. J.C. Rodriguez-Díaz, M. Ruiz, M. López, and G. Royo Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis Int J Antimicrob Agents 21 2003 354 356
7. Y. Bhusal, C. Shioshira, and N. Yamane Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis Int J Antimicrob Agents 26 2005 292 297
8. C.W. Stratton, and R.B. Cooksey A. Ballows, W.J. Hauser, K.L. Herrmann, H.D. Isenberg, H.J. Shadomy, Susceptibility test: special tests 5th ed. Manual of clinical microbiology 1991 American Society for Microbiology Washington, D.C.
9. M.H. Cynamon, Y. Zhang, T. Harpster, S. Cheng, and M.S. DeStefano High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection Antimicrob Agents Chemother 43 1999 2922 2924
10. G. Tudó, J. González, R. Obama, J.M. Rodríguez, J.R. Franco, M. Espasa, P.P. Simarro, G. Escaramís, C. Ascaso, A. García, and MTJd Anta Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology Int J Tuberc Lung Dis 8 2004 15 22
11. M.J. Ruiz-Serrano, L. Alcalá, L. Martinez, M. Díaz, M. Marin, M.J. González-Abad, and E. Bouza In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs Antimicrob Agents Chemother 44 2000 2567 2568
12. E.L. Nuermberg, T. Yoshimatsu, S. Tyagi, K. Williams, I. Rosenthal, R.J. O'Brien, A.A. Vernon, R.E. Chaisson, W.R. Bishai, and J.H. Grosset Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis Am J Respir Crit Care Med 170 2004 1131 1134
13. N. Lounis, A. Bentoucha, C. Truffot-Pernot, B. Ji, R.J. O'Brien, A. Vernon, G. Roscigno, and J. Grosset Effectiveness of one-weekly rifanpentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice Antimicrob Agents Chemother 45 2001 3482 3486
14. M.W.R. Plezt, A.D. Roux, A. Roth, K.H. Neumann, H. Mauch, and H. Lode Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study Antimicrob Agents Chemother 45 2004 780 782